Physician profile
Kathleen May
NPI 1043260672
$1,875.38
in general payments reported to CMS, 2019-2025
18 companies · $478 in 2025
The $478 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $66.57 · 2021: $22.92 · 2022: $308 · 2023: $180 · 2024: $230 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $309.93 | 2019-2025 | Nucala |
| Csl Behring | $289.19 | 2019-2025 | Hizentra, Andembry, Haegarda |
| Genzyme Corporation | $255.33 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $247.82 | 2019-2025 | Fasenra |
| Grifols USA, LLC | $104.13 | 2019-2025 | Xembify |
| Alk-Abello, INC | $95.89 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.88 | 2022-2025 | Cuvitru, Hyqvia |
| Regeneron Healthcare Solutions, INC. | $79.70 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $70.10 | 2022 | |
| Biocryst US Sales Co., LLC | $62.36 | 2025 | Orladeyo |
| Novartis Pharmaceuticals Corporation | $56.97 | 2025 | |
| Pfizer INC. | $43.24 | 2019-2022 | |
| Greer Laboratories, INC. | $37.22 | 2019-2022 | |
| Genentech USA, INC. | $35.60 | 2019 | |
| Pharming Healthcare, INC. | $33.04 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $32.91 | 2025 | Nemluvio |
| Optinose US, INC. | $17.16 | 2019 | |
| Kaleo, INC. | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.